Public Health Policies and Alcohol-related Liver Disease

Slides:



Advertisements
Similar presentations
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Advertisements

Module 3: HCV prevalence and course of HCV infection.
Liver Seminar for Health Plan Case Managers September 23, 2008 October 2, 2008.
Budesonide induces remission more effectively than Prednisone in a controlled trial of patients with Autoimmune Hepatitis GASTROENTEROLOGY 2010;139:1198–1206.
PSC and genetics Tom Hemming Karlsen
US Burden of Disease and Injury Study, 1996
Volume 63, Issue 1, Pages (July 2015)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Additional file 1: Table S1
Supplementary Table 1. Dissociation cases of EI and Fibrosis Case 1 2
Autoimmune liver disease, autoimmunity and liver transplantation
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
Volume 117, Issue 1, Pages (July 1999)
Drug-Induced Liver Injury
PNPLA3 gene in liver diseases
The Aging Liver in the Aging HIV and HCV Patients
Volume 42, Issue 6, Pages (June 2005)
Update on primary sclerosing cholangitis
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Drug-Induced Liver Injury
Acute liver failure: A curable disease by 2024?
Hepatitis C in the HIV-infected patient
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Hepatitis B and C virus-related carcinogenesis
Primary Biliary Cholangitis
European Association for the Study of the Liver  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 39, Issue 5, Pages (November 2003)
Volume 128, Issue 2, Pages (February 2005)
Genetics of liver disease: From pathophysiology to clinical practice
Autoimmune hepatitis: A life-long disease
Volume 147, Issue 2, Pages (August 2014)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C and Lymphoproliferative Disorders: From Mixed Cryoglobulinemia to Non- Hodgkin's Lymphoma  Lenna A. Martyak, Melina Yeganeh, Sammy Saab  Clinical.
Andrew Narva  American Journal of Kidney Diseases 
Trends in the management and burden of alcoholic liver disease
Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches
Volume 54, Issue 5, Pages (May 2011)
The lymphoid liver: Considerations on pathways to autoimmune injury
Guideline 1: Detection and evaluation of HCV in CKD
Liver is liver and blood is blood, and finally the twain have met
Volume 137, Issue 6, Pages (December 2009)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Unmet clinical need in autoimmune liver diseases
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Sedentary time was higher in non-alcoholic fatty liver disease (NAFLD) than healthy controls with fewer sedentary to active transitions (data reported.
Pierre Nahon, Jessica Zucman-Rossi  Journal of Hepatology 
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani
Hepatitis C Virus Diagnosis and the Holy Grail
Hepatocellular Carcinoma in Patients with
Hepatitis B and C virus-related carcinogenesis
Theresa Hydes, William Gilmore, Nick Sheron, Ian Gilmore 
Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis – Overlapping or separate diseases?  George J.M. Webster, Stephen.
AGA technical review on nonalcoholic fatty liver disease
Ethnicity and the diagnosis gap in liver disease: a population-based study by William Alazawi, Rohini Mathur, Kushala Abeysekera, Sally Hull, Kambiz Boomla,
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
HCV targeting of patients with cirrhosis
Volume 141, Issue 4, Pages (October 2011)
Volume 63, Issue 1, Pages (July 2015)
Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K
The metabolomic window into hepatobiliary disease
Promoter hypermethylation of the AE2/SLC4A2 gene in PBC
Outcomes in liver transplantation: Does sex matter?
FIG 4. Plots of the Loes scores, based on double-echo spin-echo MR images, obtained at different follow-up examinations for 22 patients with ALD. The T1-weighted.
Fig. 4: Schematic, initial diagnostic algorithm for a patient presenting with mild aminotransferase abnormality. Fig. 4: Schematic, initial diagnostic.
Presentation transcript:

Public Health Policies and Alcohol-related Liver Disease Meritxell Ventura-Cots, Maria Pilar Ballester-Ferré, Samhita Ravi, Ramon Bataller  JHEP Reports  DOI: 10.1016/j.jhepr.2019.07.009 Copyright © 2019 Terms and Conditions

Fig. 1 Lack of early detection of alcohol-related liver disease worldwide. Consecutive patients with a single (A) and double etiology (B) of liver disease seen in Gatroenterology/Liver centers from 19 patients in the 5 continents were included. Percentage of patients seen at advanced vs early stages of liver disease are shown depending on the etiology of the liver disease. *P<.05. (Adapted from Shah et al. with permission) AIH, autoimmune hepatitis; ALD, alcohol-related liver disease; DILI, drug-induced liver injury; HBV, hepatitis B virus; HCV, hepatitis C virus; HFE, hemochromatosis; NAFLD, non-alcoholic fatty liver disease; PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis. JHEP Reports DOI: (10.1016/j.jhepr.2019.07.009) Copyright © 2019 Terms and Conditions

Fig. 2 Factors known to influence excessive alcohol intake and alcohol-related liver disease. The combined effect of different factors (eg. social, environmental and genetic) influence the amount of alcohol intake at the population and individual levels. Susceptibility to develop ALD is in turn influenced by genetic and environmental factors. Abbreviations: Alcohol-related liver disease, ALD. JHEP Reports DOI: (10.1016/j.jhepr.2019.07.009) Copyright © 2019 Terms and Conditions

Fig. 3 Interactions between different policies, alcohol intake and alcoholic liver disease. Graphic representation of the combined effect and interactions between different types of public health policies. The represented polices will impact alcohol consumption and subsequently can reduce the burden of ALD. Abbreviations: Alcohol-related liver disease, ALD. The images are licenced by Creative Commons. JHEP Reports DOI: (10.1016/j.jhepr.2019.07.009) Copyright © 2019 Terms and Conditions